Warby Parker Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Warby Parker Inc.
Former names: JAND, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 3851 — Ophthalmic Goods
Jurisdiction of incorporation: Delaware
Headquarters city: New York
Headquarters state / province: New York
Headquarters country: United States
Fiscal year end: December
Ticker symbol: WRBY
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001504776
EIN: 80-0423634
Wikidata ID: Q7968882

Board of directors

Follow this board

Andrew Hunt · Director
Since 2023
Bradley E. Singer · Director
Since 2024
David Abraham Gilboa · Director · Co-Chief Executive Officer
Since 2023
Gabrielle Sulzberger · Director
Since 2023
Jeffrey Jacob Raider · Director
Since 2023
Joel E. Cutler · Director
Since 2025
Neil Harris Blumenthal · Director · Co-Chief Executive Officer
Since 2023
Ronald A. Williams · Director
Since 2023
Teresa Briggs · Director
Since 2023
Youngme E. Moon · Director
Since 2023

Chief executives

David Abraham Gilboa · Co-Chief Executive Officer

Dates unknown

Neil Harris Blumenthal · Co-Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

6 of this board's directors also sit on 10 other boards. 2 are in the same sector.

Shared director Other board Same sector

Sweetgreen Inc.
via Bradley E. Singer, Neil Harris Blumenthal and Youngme E. Moon
Mastercard Incorporated
via Gabrielle Sulzberger and Youngme E. Moon
Crown Castle Inc.
via Bradley E. Singer
DocuSign Inc.
via Teresa Briggs
Eli Lilly and Company Same sector
via Gabrielle Sulzberger
ServiceNow Inc.
via Teresa Briggs
Smartbird Inc.
via Neil Harris Blumenthal
Snowflake Inc.
via Teresa Briggs
The Boeing Company
via Ronald A. Williams
agilon health inc. Same sector
via Ronald A. Williams

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $50,304,293; 35 sales by 7 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 1, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+95,614	—	—
Oct 1, 2026	Jeffrey Jacob Raider Director	Open-market sale	−15,000	$27.70	$415,500
Oct 1, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Open-market sale	−100,000	$27.69	$2,769,000
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Option exercise	+9,815	—	—
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Option exercise	+9,815	—	—
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Option exercise	+10,983	—	—
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Option exercise	+10,983	—	—
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Shares withheld for tax	−11,504	$24.19	$278,282
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Shares withheld for tax	−11,504	$24.19	$278,282
Jul 6, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+9,200	—	—
Jul 6, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+54,347	—	—
Jul 6, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Open-market sale	−9,200	$29.99	$275,908
Jul 6, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Open-market sale	−54,347	$29.84	$1,621,714
Jul 1, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+189,320	—	—
Jul 1, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+213,746	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Warby Parker Inc.

Who is the CEO of Warby Parker Inc.?

David Abraham Gilboa is Warby Parker Inc.'s Co-Chief Executive Officer.

How many directors are on Warby Parker Inc.'s board?

Warby Parker Inc.'s board has 10 directors: Andrew Hunt, Bradley E. Singer, David Abraham Gilboa, Gabrielle Sulzberger, Jeffrey Jacob Raider, Joel E. Cutler, Neil Harris Blumenthal, Ronald A. Williams, Teresa Briggs and Youngme E. Moon.

Are Warby Parker Inc. insiders buying or selling shares?

Over the last 12 months, Warby Parker Inc. insiders made no open-market purchases and sold $50.3 million of shares in 35 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Warby Parker Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="warby-parker-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.